Abstract
Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specifi c neutralizing antibodieswere detected for 6 years postinfection.
Cite
CITATION STYLE
APA
Alshukairi, A. N., Zhao, J., Al-Mozaini, M. A., Wang, Y., Dada, A., Baharoon, S. A., … Memish, Z. A. (2021). Longevity of middle east respiratory syndrome coronavirus antibody responses in humans, saudi arabia. Emerging Infectious Diseases, 27(5), 1472–1476. https://doi.org/10.3201/eid2705.204056
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free